Literature DB >> 9770558

Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status.

R Moreno-Reyes1, C Suetens, F Mathieu, F Begaux, D Zhu, M T Rivera, M Boelaert, J Nève, N Perlmutter, J Vanderpas.   

Abstract

BACKGROUND AND METHODS: Kashin-Beck disease is a degenerative osteoarticular disorder that is endemic to certain areas of Tibet, where selenium deficiency is also endemic. Because selenium is involved in thyroid hormone metabolism, we studied the relation among the serum selenium concentration, thyroid function, and Kashin-Beck disease in 575 subjects 5 to 15 years of age in 12 villages around Lhasa, Tibet, including 1 control village in which no subject had Kashin-Beck disease. Clinical, radiologic, and biochemical data were collected.
RESULTS: Among the 575 subjects, 280 (49 percent) had Kashin-Beck disease, 267 (46 percent) had goiter, and 7 (1 percent) had cretinism. Of the 557 subjects in whom urinary iodine was measured, 66 percent had a urinary iodine concentration of less than 2 microg per deciliter (157 nmol per liter; normal, 5 to 25 microg per deciliter [394 to 1968 nmol per liter]). The mean urinary iodine concentration was lower in subjects with Kashin-Beck disease than in control subjects (1.2 vs. 1.8 microg per deciliter [94 vs. 142 nmol per liter], P<0.001) and hypothyroidism was more frequent (23 percent vs. 4 percent, P=0.01). Severe selenium deficiency was documented in all villages; 38 percent of subjects had serum concentrations of less than 5 ng per milliliter (64 nmol per liter; normal, 60 to 105 ng per milliliter [762 to 1334 nmol per liter]). When age and sex were controlled for in a multivariate analysis, low urinary iodine, high serum thyrotropin, and low serum thyroxine-binding globulin values were associated with an increased risk of Kashin-Beck disease, but a low serum selenium concentration was not.
CONCLUSIONS: In areas where severe selenium deficiency is endemic, iodine deficiency is a risk factor for Kashin-Beck disease.

Entities:  

Keywords:  Asia; Biology; China; Deficiency Diseases; Demographic Factors; Developing Countries; Diseases; Eastern Asia; Micronutrients; Nutrition Disorders; Physiology; Population; Population Characteristics; Research Report; Rural Population

Mesh:

Substances:

Year:  1998        PMID: 9770558     DOI: 10.1056/NEJM199810153391604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  58 in total

1.  A search for the evidence supporting community paediatric practice.

Authors:  M C Rudolf; N Lyth; A Bundle; G Rowland; A Kelly; S Bosson; M Garner; P Guest; M Khan; R Thazin; T Bennett; D Damman; V Cove; V Kaur
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

2.  Biological reference values for chemical compounds in the work area (BARs): an approach for evaluating biomonitoring data.

Authors:  Thomas Göen; Karl-Heinz Schaller; Hans Drexler
Journal:  Int Arch Occup Environ Health       Date:  2011-09-30       Impact factor: 3.015

Review 3.  Cartilage cell clusters.

Authors:  Martin K Lotz; Shuhei Otsuki; Shawn P Grogan; Robert Sah; Robert Terkeltaub; Darryl D'Lima
Journal:  Arthritis Rheum       Date:  2010-08

4.  Measuring health-related quality of life in Kashin-Beck disease using EQ-5D.

Authors:  Umer Farooq; Xiong Guo; Ling-Hsiang Chuang; Hua Fang; Guihua Zhuang; Chuantao Xia
Journal:  Qual Life Res       Date:  2010-12-24       Impact factor: 4.147

5.  Effects of physical environment on the evolution of Kashin-Beck disease in Tibet.

Authors:  M Hinsenkamp; F Mathieu; W Claus; J-F Collard; V de Maertelaer
Journal:  Int Orthop       Date:  2009-03-17       Impact factor: 3.075

6.  Risk factors for incident osteoarthritis of the hip and knee.

Authors:  R Krishna Chaganti; Nancy E Lane
Journal:  Curr Rev Musculoskelet Med       Date:  2011-09

7.  The effectiveness of treatments for Kashin-Beck disease: a systematic review and network meta-analysis.

Authors:  Kun Zou; Jinliang Hu; Qiao Zhou; Jiang Su; Birong Dong; Weiya Zhang
Journal:  Clin Rheumatol       Date:  2019-08-02       Impact factor: 2.980

Review 8.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Clinical features of Kashin-Beck disease in adults younger than 50 years of age during a low incidence period: severe elbow and knee lesions.

Authors:  Yong Li; Zongke Zhou; Bin Shen; Jing Yang; Pengde Kang; Xiaobo Yang; Gang Liu; Fuxing Pei
Journal:  Clin Rheumatol       Date:  2012-12-08       Impact factor: 2.980

10.  Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease.

Authors:  Charlene M Downey; Chelsea R Horton; Bradley A Carlson; Trish E Parsons; Dolph L Hatfield; Benedikt Hallgrímsson; Frank R Jirik
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.